These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 3036865

  • 1. Mechanism of inhibition of glycolysis by vanadate.
    Benabe JE, Echegoyen LA, Pastrana B, Martínez-Maldonado M.
    J Biol Chem; 1987 Jul 15; 262(20):9555-60. PubMed ID: 3036865
    [Abstract] [Full Text] [Related]

  • 2. Mechanism of inhibition of glycolysis by vanadate.
    Benabe JE, Echegoyen LA, Martínez-Maldonado M.
    Adv Exp Med Biol; 1986 Jul 15; 208():517-28. PubMed ID: 3031951
    [No Abstract] [Full Text] [Related]

  • 3. Vanadyl (IV) and vanadate (V) binding to selected endogenous phosphate, carboxyl, and amino ligands; calculations of cellular vanadium species distribution.
    Nechay BR, Nanninga LB, Nechay PS.
    Arch Biochem Biophys; 1986 Nov 15; 251(1):128-38. PubMed ID: 3789729
    [Abstract] [Full Text] [Related]

  • 4. Vanadate inhibition of the Ca2+-ATPase from human red cell membranes.
    Barrabin H, Garrahan PJ, Rega AF.
    Biochim Biophys Acta; 1980 Aug 14; 600(3):796-804. PubMed ID: 6447514
    [Abstract] [Full Text] [Related]

  • 5. Vanadyl (VO2+) and vanadate (VO-3) ions inhibit the brain microsomal Na,K-ATPase with similar affinities. Protection by transferrin and noradrenaline.
    Svoboda P, Teisinger J, Pilăr J, Vyskocil F.
    Biochem Pharmacol; 1984 Aug 01; 33(15):2485-91. PubMed ID: 6087831
    [Abstract] [Full Text] [Related]

  • 6. Vanadate affects glucose metabolism of human erythrocytes.
    Ninfali P, Accorsi A, Fazi A, Palma F, Fornaini G.
    Arch Biochem Biophys; 1983 Oct 15; 226(2):441-7. PubMed ID: 6556902
    [Abstract] [Full Text] [Related]

  • 7. Significance of NADH-vanadate-oxidoreductase of cardiac and erythrocyte cell membranes.
    Erdmann E, Werdan K, Krawietz W, Lebuhn M, Christl S.
    Basic Res Cardiol; 1980 Oct 15; 75(3):460-5. PubMed ID: 6255934
    [Abstract] [Full Text] [Related]

  • 8. The mechanism of vanadium action on selective K+-permeability in human erythrocytes.
    Fuhrmann GF, Hüttermann J, Knauf PA.
    Biochim Biophys Acta; 1984 Jan 11; 769(1):130-40. PubMed ID: 6419778
    [Abstract] [Full Text] [Related]

  • 9. The effects of several ligands on the potassium-vanadate interaction in the inhibition of the (Na+ + K+)-ATPase and the Na+, K+ pump.
    Beaugé L, Berberian G.
    Biochim Biophys Acta; 1983 Jan 19; 727(2):336-50. PubMed ID: 6301556
    [Abstract] [Full Text] [Related]

  • 10. Stimulation of human erythrocyte 2,3-bisphosphoglycerate phosphatase by vanadate.
    Mendz GL, Hyslop SJ, Kuchel PW.
    Arch Biochem Biophys; 1990 Jan 19; 276(1):160-71. PubMed ID: 2153361
    [Abstract] [Full Text] [Related]

  • 11. Influence of vanadate on glycolysis, intracellular sodium, and pH in perfused rat hearts.
    Geraldes CF, Castro MM, Sherry AD, Ramasamy R.
    Mol Cell Biochem; 1997 May 19; 170(1-2):53-63. PubMed ID: 9144318
    [Abstract] [Full Text] [Related]

  • 12. Stimulation of mutases and isomerases by vanadium.
    Mendz GL.
    Arch Biochem Biophys; 1991 Dec 19; 291(2):201-11. PubMed ID: 1659318
    [Abstract] [Full Text] [Related]

  • 13. Structures of ATP(adenosine triphosphate)-vanadyl complexes.
    Sakurai H, Goda T, Shimomura S, Yoshimura T.
    Nucleic Acids Symp Ser; 1982 Dec 19; (11):253-6. PubMed ID: 6306604
    [Abstract] [Full Text] [Related]

  • 14. The fate of cytoplasmic vanadium. Implications on (NA,K)-ATPase inhibition.
    Cantley LC, Aisen P.
    J Biol Chem; 1979 Mar 25; 254(6):1781-4. PubMed ID: 217870
    [Abstract] [Full Text] [Related]

  • 15. Metabolism of added orthovanadate to vanadyl and high-molecular-weight vanadates by Saccharomyces cerevisiae.
    Willsky GR, White DA, McCabe BC.
    J Biol Chem; 1984 Nov 10; 259(21):13273-81. PubMed ID: 6386812
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of glycolysis by ethacrynic acid and furosemide.
    Klahr S, Yates J, Bourgoignie J.
    Am J Physiol; 1971 Oct 10; 221(4):1038-43. PubMed ID: 5111246
    [No Abstract] [Full Text] [Related]

  • 17. Reduction of Vanadate by ascorbic acid and noradrenaline in synaptosomes.
    Adám-Vizi V, Váradi G, Simon P.
    J Neurochem; 1981 May 10; 36(5):1616-20. PubMed ID: 6264031
    [Abstract] [Full Text] [Related]

  • 18. Vanadium increases selective K+-permeability in human erythrocytes.
    Siemon H, Schneider H, Fuhrmann GF.
    Toxicology; 1981 May 10; 22(4):271-8. PubMed ID: 7342369
    [Abstract] [Full Text] [Related]

  • 19. Glutathione reduces cytoplasmic vanadate. Mechanism and physiological implications.
    Macara IG, Kustin K, Cantley LC.
    Biochim Biophys Acta; 1980 Apr 17; 629(1):95-106. PubMed ID: 6245716
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of (Na,K)-ATPase by tetravalent vanadium.
    North P, Post RL.
    J Biol Chem; 1984 Apr 25; 259(8):4971-8. PubMed ID: 6325413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.